- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05533658
The Effects of VisionPure™ on Indices of Vision Health and Cognitive Function
May 25, 2023 updated by: Applied Science & Performance Institute
The Effects of VisionPure™ on Indices of Vision Health and Cognitive Function: A Randomized, Double-Blind, Placebo-Controlled, Parallel Pilot Trial.
VisionPure™ is a softgel dietary supplement containing fish oil, lutein, zeaxanthin, and vitamin D. The intent of the VisionPure product is to assist in maintaining eye and cognitive health while helping to provide protection against blue throughout the day.
In this pilot trial, approximately 16 participants will be recruited and randomly assigned to experimental and placebo conditions.
Participants will consume 1 serving (2 softgels) per day of their respective study condition for 60 days.
Prior to and following the 60 day supplementation period, participants will undergo a series of optometry and cognitive examinations to quantify eye health and cognitive function outcomes.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The study design is a randomized, double-blind, placebo-controlled, parallel design, pilot trial.
In this pilot trial, approximately 16 participants will be recruited and randomly assigned to experimental and placebo conditions.
Participants will consume 1 serving (2 softgels) per day of their respective study condition for 60 days.
All study-related procedures will be carried out at 2 locations, The Applied Science and Performance Institute, as well as at True Eye Experts.
Both locations are in Tampa, FL.
All screening for the study and the signing of all IRB documents will be held at the Applied Science and Performance Institute.
Optometry eye examination at Day 0 and Day 60 will be conducted under the supervision of a board-certified O.D. at the True Eye Experts location.
Computer-based cognitive assessments using a program called CNS Vital Signs will be carried out at Day 0 and Day 60 at the Applied Science and Performance Institute.
The following exams will be carried out: Verbal Memory, Visual Memory, Composite Memory, and Cognitive Attention.
Study Type
Interventional
Enrollment (Actual)
15
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Florida
-
Lutz, Florida, United States, 33549
- True Eye Experts - Lutz
-
Tampa, Florida, United States, 33607
- Applied Science and Performance Institute
-
Tampa, Florida, United States, 33647
- True Eye Experts - New Tampa
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Male or female
- Age 18-40 years
- English literate
- Willing to sign informed consent form
Exclusion Criteria:
- Current cataracts or prior cataract extraction
- Glaucoma
- Uveitis
- Macular hole or traction
- Retinitis pigmentosa
- Significant epiretinal membrane
- Dry eye syndrome of any form
- LASIK procedure
- Diagnosed concussion within the last 6 months
- Optic neuropathy
- Neurological disease
- Metabolic disease
- Cardiovascular disease
- Renal disease
- History of previous ocular surgery, trauma, intraocular injections or photocoagulation
- Vitamin D3, omega fatty acids, or fish oil supplementation with the last 6 months
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: VisionPure Dietary Supplement
One dose (2 softgel capsules) will be consumed once daily for 60 days.
A single dose contains: 976mg fish oil (120mg eicosapentaenoic acid, 610 mg docosahexaenoic acid), 20mg lutein, 4mg zeaxanthin isomers, 25mcg vitamin D3.
|
Subjects will consume two softgels capsules of the Treatment (VisionPure) once daily for 60 days.
At Day 0, they will come in for a Comprehensive Eye Exam, a National Eye Institute Visual Functioning Questionnaire, and a series of Cognitive Function Exams.
After 60 days, subjects will return and repeat the same questionnaires and exams from Day 0.
|
|
Placebo Comparator: Placebo
One dose (2 softgel capsules) will be consumed once daily for 60 days.
A single dose contains: 727mg organic sunflower oil, 15mg organic lemon essential oil, 1.5mg vitamin E T-70, 0.7mg natural fish flavor.
|
Subjects will orally consume two softgel capsules of Placebo once daily for 60 days.
At Day 0, they will come in for a Comprehensive Eye Exam, a National Eye Institute Visual Functioning Questionnaire, and a series of Cognitive Function Exams.
After 60 days, subjects will return and repeat the same questionnaires and exams from Day 0.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Ganglion Cell Complex Thickness
Time Frame: Day 0, Day 60
|
Diagnostic Procedure: Retinal Optical Coherence Tomography
|
Day 0, Day 60
|
|
Change in Central Retinal Thickness
Time Frame: Day 0, Day 60
|
Diagnostic Procedure: Retinal Optical Coherence Tomography
|
Day 0, Day 60
|
|
Change in Intraocular Pressure
Time Frame: Day 0, Day 60
|
Diagnostic Procedure: Retinal Optical Coherence Tomography
|
Day 0, Day 60
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Visual Acuity
Time Frame: Day 0, Day 60
|
Determines the clarity of your distance vision according to the Snellen Chart.
|
Day 0, Day 60
|
|
Change in Color Vision
Time Frame: Day 0, Day 60
|
Determines the normality of or defectiveness of color vision.
Reference Range: 1 to 11 according to Ishihara Plates (>10 is normal, 7 or <7 is deficient).
|
Day 0, Day 60
|
|
Change in Verbal Memory
Time Frame: Day 0, Day 60
|
How well can an individual recognize, remember, and recall words.
|
Day 0, Day 60
|
|
Change in Visual Memory
Time Frame: Day 0, Day 60
|
How well can in individual recognize, remember, and recall a combination of words and images.
|
Day 0, Day 60
|
|
Change in Composite Memory
Time Frame: Day 0, Day 60
|
How well an individual can recognize, remember, and recall a combination of words and images.
|
Day 0, Day 60
|
|
Change in Cognitive Attention
Time Frame: Day 0, Day 60
|
The ability to handle multiple tasks at once and shift attention.
|
Day 0, Day 60
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in National Eye Institute Visual Functioning Questionnaire - 25 (VFQ-25)
Time Frame: Day 0, Day 60
|
Subjective/Self-Reported Eye Health Questionnaire.
|
Day 0, Day 60
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Jacob Wilson, Ph.D., The Applied Science and Performance Institute
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2022
Primary Completion (Actual)
January 30, 2023
Study Completion (Actual)
February 3, 2023
Study Registration Dates
First Submitted
September 6, 2022
First Submitted That Met QC Criteria
September 6, 2022
First Posted (Actual)
September 9, 2022
Study Record Updates
Last Update Posted (Actual)
May 26, 2023
Last Update Submitted That Met QC Criteria
May 25, 2023
Last Verified
October 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- 1221
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cognitive Function
-
National Taipei University of Nursing and Health...Active, not recruitingCognitive Function | Physical FunctionTaiwan
-
University School of Physical Education in WroclawActive, not recruitingCognitive Function | Executive FunctionPoland
-
Maastricht UniversityWageningen University and Research; Top Institute Food and Nutrition; Netherlands...TerminatedCognitive Function | Ageing | Physical Function | Mitochondrial FunctionNetherlands
-
University Hospital, GenevaCompletedCognitive Function | Falls | Physical FunctionSwitzerland
-
University of FloridaNational Institutes of Health (NIH); National Institute on Aging (NIA)CompletedCognitive Function | Older Adults | Physical FunctionUnited States
-
Columbia UniversityNational Institute on Aging (NIA)Terminated
-
Örebro University, SwedenActive, not recruitingCognitive FunctionSweden
-
Radicle ScienceCompletedCognitive FunctionUnited States
-
Radicle ScienceCompletedCognitive FunctionUnited States
-
Radicle ScienceCompletedCognitive FunctionUnited States
Clinical Trials on VisionPure Dietary Supplement
-
Bionos Biotech S.L.CompletedSkin Hydration in Healthy Volunteers | Skin Ageing | Facial Wrinkles - Rough Texture - HyperpigmentationSpain
-
University of Novi Sad, Faculty of Sport and Physical...Completed
-
Fonterra Research CentreCompleted
-
Biosearch S.A.Universidad de Granada; University Hospital Virgen de las NievesTerminatedKnee DiscomfortSpain
-
Universidade Federal do AmazonasCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.; Hospital Universitario... and other collaboratorsCompletedOverweight | HypercholesterolemiaBrazil
-
Larissa University HospitalRecruitingDumping Syndrome | Gastric SurgeryGreece
-
Texas Tech UniversityEHP LabsCompletedBody Weight Changes | Body Composition Changes | Anthropometric Changes | Metabolism Changes | Hemodynamic ChangesUnited States
-
University Hospital OstravaRecruitingCritical Illness | Prolonged Mechanical VentilationCzechia
-
Ultra Botanica LLCActive, not recruitingJoint Discomfort | Quality of Life (QOL)United States
-
NeuroEnergy Ventures, Inc.Active, not recruiting